1-ethyl-2-oxo-1-pyrrolidine acetic acid,
2-(2-oxopyrrolidin-1-yl)butanoic acid,
2-pyrrilidone-N-butyric acid,
Imp-2 cpd,
2-(2-oxopyrrolidin-1-yl)butanoic Acid,
67118-31-4,
alpha-Ethyl-2-oxo-1-pyrrolidineacetic acid,
Levetiracetam impurity A,
(2RS)-2-(2-Oxopyrrolidin-1-yl)butanoic acid,
Levetiracetam Carboxylic Acid,
Levetiracetam acid, (+/-)-,
Levetiracetam specified impurity A [EP],
ACMC-209vls,
1-Pyrrolidineacetic acid, alpha-ethyl-2-oxo-,
2-(2-Oxopyrrolidin-1-yl)butanoic acid, (2RS)-,
2-(2-Oxopyrrolidin-1-yl)butanoic acid, (+/-)-,
SCHEMBL1747843,
CTK8B4203,
IODGAONBTQRGGG-UHFFFAOYSA-N,
BCP10279,
5018AF,
ANW-44270,
CE-205,
STL451037,
AKOS005216477,
AKOS016842777,
MCULE-2438910115,
NE13780,
TRA0051850,
2-(2-oxopyrrolidin-1-yl) butyric acid,
SC-15311,
AB0178276,
DB-022453,
TC-070234,
FT-0080811,
FT-0652183,
EN300-90324,
Dimethylbis(pentamethylcyclopentadienyl)zirconium,
(RS)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid,
racemic alpha-ethyl-2-oxo-1-pyrrolidineacetic acid,
I04-0436,
I04-0437,
I04-0438,
Not Available,
Levetiracetam acid,
UNII-T5GZ0UL12V,
T5GZ0UL12V,
C8H13NO3,
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid,
CS-O-07882,
CID10464751,
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoicacid,
(S)-2-(2-oxopyrrolidin-1-yl)butanoic acid,
102849-49-0,
(2s)-2- (2- oxopyrrolidin -1-yl) butanoic acid,
103833-72-3,